About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Rheumatology Research Group (GRR) is focused on translational research in immunity-mediated inflammatory diseases (IMIDA), mainly in the area of rheumatology. The GRR is a multidisciplinary group made up of clinical specialists, biologists, bioinformaticians and laboratory technicians. The different research lines of the GRR emphasize the use of high-performance technologies for the study at the cellular and molecular level of the immununopathology of IMIDA, mainly chronic inflammatory arthritis and autoimmune systemic diseases.
At the clinical level, we have developed lines of research in very diverse areas of rheumatology, including chronic inflammatory arthritis (rheumatoid arthritis, spondyloarthropathies), systemic autoimmune diseases (lupus, myositis, Sjögren's syndrome), the study of musculoskeletal imaging, pediatric rheumatology (juvenile idiopathic arthritis, autoimmune systemic diseases, autoinflammatory syndromes), central sensitization syndromes and the study of bone metabolism. One of the main objectives of the GRR is the coordination of basic and clinical research to accelerate the transfer of knowledge to clinical practice and thus improve the quality of life of patients.
PMID: 35156620 Journal: European journal of rheumatology Year: 2022 Reference: Eur J Rheumatol. 2022 Oct;9(4):191-196. doi: 10.5152/eujrheum.2022.20012. Impact factor: Publication type: Paper in international publication Authors: Alsina, Laia; Baniandres, Ofelia; Caliz, Rafael; Casellas, Manel; Grados, Dolors; Martinez Lopez, Juan Antonio; Pego Reigosa, Jose Maria; Perez, Erika Padron; Pluma, Andrea; Polo, Ana et al. DOI: 10.5152/eujrheum.2022.20012
PMID: 34973429 Journal: CLINICAL IMMUNOLOGY Year: 2022 Reference: Clin Immunol. 2022 Jan;234:108920. doi: 10.1016/j.clim.2021.108920. Epub 2021 Dec 29. Impact factor: Publication type: Review in international publication Authors: Ballestar, Esteban; Cortes-Hernandez, Josefina; Ferrete-Bonastre, Anna Guiomar et al. DOI: 10.1016/j.clim.2021.108920
PMID: 34861974 Journal: Biological Psychiatry Year: 2022 Reference: Biol Psychiatry. 2022 Feb 1;91(3):313-327. doi: 10.1016/j.biopsych.2021.05.029. Epub 2021 Sep 9. Impact factor: Publication type: Paper in international publication Authors: Abdellaoui, Abdel; Abramova, Liliya; Adams, Mark; Adams, Mark J; Adan, Roger A H; Adolfsson, Rolf; Adolfsson, Rolf; Adorjan, Kristina; Agartz, Ingrid; Agartz, Ingrid et al. DOI: 10.1016/j.biopsych.2021.05.029
PMID: 36597989 Journal: RMD Open Year: 2022 Reference: RMD Open. 2022 Dec;8(2):e002513. doi: 10.1136/rmdopen-2022-002513. Impact factor: Publication type: Paper in international publication Authors: Collantes, Eduardo; Erra, Alba; Font-Ugalde, Pilar; Juanola, Xavier; Lopez-Medina, Clementina; Marzo-Ortega, Helena; Michelena, Xabier et al. DOI: 10.1136/rmdopen-2022-002513
PMID: 33603102 Journal: Scientific Reports Year: 2021 Reference: Sci Rep. 2021 Feb 18;11(1):4215. doi: 10.1038/s41598-021-83762-4. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Carioti, Luca; Casillas, Rosario; Cortese, Maria Francesca; Esteban-Mur, Rafael; Garcia-Garcia, Selene; Godoy, Cristina; Gonzalez, Carolina; Gregori, Josep; Guerrero-Murillo, Mercedes et al. DOI: 10.1038/s41598-021-83762-4
PMID: 33353469 Journal: ANTIOXIDANTS & REDOX SIGNALING Year: 2021 Reference: Antioxid Redox Signal. 2021 Jun 20;34(18):1420-1427. doi: 10.1089/ars.2020.8230. Epub 2021 Feb 11. Impact factor: Publication type: Paper in international publication Authors: Alegre-Martin, Jose; Castro-Marrero, Jesus; Cordobilla, Begona; Domingo, Joan Carles; Ferrer, Roser; Giralt, Marina et al. DOI: 10.1089/ars.2020.8230
PMID: 33217613 Journal: Journal of Allergy and Clinical Immunology-In Practice Year: 2021 Reference: J Allergy Clin Immunol Pract. 2021 Feb;9(2):803-818.e11. doi: 10.1016/j.jaip.2020.11.007. Epub 2020 Nov 18. Impact factor: Publication type: Paper in international publication Authors: Bader-Meunier, Brigitte; Barnabei, Laura; Belot, Alexandre; Berteloot, Laureline; Blanche, Stephane; Bondet, Vincent; Bresson, Violaine; Breton, Sylvain; Brocq, Olivier; Chan, Damien et al. DOI: 10.1016/j.jaip.2020.11.007
PMID: 32658963 Journal: RHEUMATOLOGY Year: 2021 Reference: Rheumatology (Oxford). 2021 Jan 5;60(1):217-223. doi: 10.1093/rheumatology/keaa247. Impact factor: Publication type: Paper in international publication Authors: Carballo, Iago; de Miguel-Campo, Borja; Feijoo-Masso, Carlos; Fernandez-Codina, Andreu; Fonseca-Aizpuru, Eva; Hernandez-Rodriguez, Jose; Lopez-Dupla, Miguel; Martinez-Valle, Fernando; Pinal-Fernandez, Iago; Pinilla, Blanca et al. DOI: 10.1093/rheumatology/keaa247
PMID: 31996780 Journal: Scientific Reports Year: 2020 Reference: Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0. Impact factor: Publication type: Paper in international publication Authors: Balsa, Alejandro; Bonilla, Gema; Calvo-Alen, Jaime; Castaneda, Santos; Cavagna, Lorenzo; Cifrian, Jose M; Cuesta, Victor M Mora; Fernandez, David Iturbe; Gafas, Alicia De Pablo; Genre, Fernanda et al. DOI: 10.1038/s41598-020-58400-0
PMID: 31963773 Journal: International Journal of Environmental Research and Public Health Year: 2020 Reference: Int J Environ Res Public Health. 2020 Jan 19;17(2). pii: ijerph17020634. doi: 10.3390/ijerph17020634. Impact factor: Publication type: Paper in international publication Authors: Almirall, Miriam; Feliu-Soler, Albert; Fontcuberta, Anna; Garcia-Troiteiro, Elna; Luciano, Juan V; Mateo-Canedo, Corel; Mendez-Ulrich, Jorge Luis; Sanabria-Mazo, Juan P; Sanz, Antoni; Serrat, Mayte et al. DOI: 10.3390/ijerph17020634
PMID: 31838162 Journal: AUTOIMMUNITY REVIEWS Year: 2020 Reference: Autoimmun Rev. 2020 Feb;19(2):102455. doi: 10.1016/j.autrev.2019.102455. Epub 2019 Dec 12. Impact factor: Publication type: Review in international publication Authors: Antoniol, Maria Noelia; Cabrera, Carlos; Castrejon, Natalia; Grau, Josep Maria; Matas-Garcia, Ana; Milisenda, Jose C; Padrosa, Joan; Prieto-Gonzalez, Sergio; Reguart, Noemi; Ros, Javier et al. DOI: 10.1016/j.autrev.2019.102455
PMID: 31906988 Journal: Journal of Translational Medicine Year: 2020 Reference: J Transl Med. 2020 Jan 6;18(1):4. doi: 10.1186/s12967-019-02184-z. Impact factor: Publication type: Paper in international publication Authors: Alegre, Jose; Capdevila, Lluis; Castro, Juan Ramos; Castro-Marrero, Jesus; Escorihuela, Rosa Maria; Maurel, Sara; Zaragoza, Maria Cleofe et al. DOI: 10.1186/s12967-019-02184-z
Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs
The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.
It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.
